Biodesix, Inc. (BDSX)
26.02
+0.39
(+1.52%)
USD |
NASDAQ |
Oct 09, 16:00
26.02
0.00 (0.00%)
After-Hours: 20:00
Biodesix Net Income (Quarterly) : -7.273M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.273M |
| March 31, 2026 | -7.793M |
| December 31, 2025 | -3.98M |
| September 30, 2025 | -8.716M |
| June 30, 2025 | -11.47M |
| March 31, 2025 | -11.10M |
| December 31, 2024 | -8.251M |
| September 30, 2024 | -10.26M |
| June 30, 2024 | -10.81M |
| March 31, 2024 | -13.61M |
| December 31, 2023 | -9.139M |
| September 30, 2023 | -10.95M |
| June 30, 2023 | -13.36M |
| March 31, 2023 | -18.70M |
| Date | Value |
|---|---|
| December 31, 2022 | -20.34M |
| September 30, 2022 | -13.70M |
| June 30, 2022 | -15.82M |
| March 31, 2022 | -15.59M |
| December 31, 2021 | -13.28M |
| September 30, 2021 | -11.51M |
| June 30, 2021 | -11.40M |
| March 31, 2021 | -6.961M |
| December 31, 2020 | -4.533M |
| September 30, 2020 | -8.845M |
| June 30, 2020 | -8.266M |
| March 31, 2020 | -9.705M |
| December 31, 2019 | -6.525M |
| September 30, 2019 | -9.601M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 333.00M |
| Labcorp Holdings, Inc. | 299.10M |
| OPKO Health, Inc. | -8.416M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.238M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 26.86M |
| Total Expenses (Quarterly) | 34.13M |
| EPS Diluted (Quarterly) | -0.7064 |
| Enterprise Value | 316.21M |
| Gross Profit Margin (Quarterly) | 82.06% |
| Profit Margin (Quarterly) | -27.08% |
| Earnings Yield | -12.18% |
| Normalized Earnings Yield | -12.17 |